752 related articles for article (PubMed ID: 22077195)
21. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
[TBL] [Abstract][Full Text] [Related]
22. Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan.
Ishiguro N; Koseki N; Kaiho M; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hazama K; Watanabe T; Sasaki S; Horino A; Kenri T; Ariga T;
Jpn J Infect Dis; 2016 May; 69(3):186-90. PubMed ID: 26166502
[TBL] [Abstract][Full Text] [Related]
23. Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples.
Ji M; Lee NS; Oh JM; Jo JY; Choi EH; Yoo SJ; Kim HB; Hwang SH; Choi SH; Lee SO; Kim MN; Sung H
J Microbiol Methods; 2014 Jul; 102():32-6. PubMed ID: 24780151
[TBL] [Abstract][Full Text] [Related]
24. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
25. [Macrolide-resistant Mycoplasma pneumoniae].
Morozumi M; Ubukata K
Nihon Rinsho; 2012 Feb; 70(2):251-5. PubMed ID: 22413527
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.
Suzuki S; Yamazaki T; Narita M; Okazaki N; Suzuki I; Andoh T; Matsuoka M; Kenri T; Arakawa Y; Sasaki T
Antimicrob Agents Chemother; 2006 Feb; 50(2):709-12. PubMed ID: 16436730
[TBL] [Abstract][Full Text] [Related]
27. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients.
Wagner K; Imkamp F; Pires VP; Keller PM
Clin Microbiol Infect; 2019 Mar; 25(3):383.e5-383.e7. PubMed ID: 30391582
[TBL] [Abstract][Full Text] [Related]
29. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
[TBL] [Abstract][Full Text] [Related]
30. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
[TBL] [Abstract][Full Text] [Related]
31. Development of macrolide resistance in Mycoplasma pneumoniae-infected Swedish patients treated with macrolides.
Nilsson AC; Jensen JS; Björkman P; Persson K
Scand J Infect Dis; 2014 Apr; 46(4):315-9. PubMed ID: 24447251
[TBL] [Abstract][Full Text] [Related]
32. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.
Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S
J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728
[TBL] [Abstract][Full Text] [Related]
33. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
[TBL] [Abstract][Full Text] [Related]
34. Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.
Wu HM; Wong KS; Huang YC; Lai SH; Tsao KC; Lin YJ; Lin TY
J Infect Chemother; 2013 Aug; 19(4):782-6. PubMed ID: 23196653
[TBL] [Abstract][Full Text] [Related]
35. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
[TBL] [Abstract][Full Text] [Related]
36. Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae.
Guo D; Hu W; Xu B; Li J; Li D; Li S; Wu Z; Wei R; Tian X; Shen K; Xin D
BMC Infect Dis; 2019 Jul; 19(1):616. PubMed ID: 31299916
[TBL] [Abstract][Full Text] [Related]
37. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
38. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
[TBL] [Abstract][Full Text] [Related]
39. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK.
Ferguson GD; Gadsby NJ; Henderson SS; Hardie A; Kalima P; Morris AC; Hill AT; Cunningham S; Templeton KE
J Med Microbiol; 2013 Dec; 62(Pt 12):1876-1882. PubMed ID: 24008501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
